MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ctro.2026.101121

Медицинская библиотека · Clinical and translational radiation oncology · 2026

Prognosis of patients with early salvage radiotherapy and low persisting or increasing PSA levels after radical prostatectomy for prostate cancer. A retrospective comparative analysis.

Thamm Reinhard, Scharl Sophia, Gartner Luca, Böhmer Dirk Heinz Gerhard, Siegmann Alessandra, Zips Daniel, Horsch Cornelia, Mayer Benjamin, Wiegel Thomas

СтатьяПеревод пока не подготовлен

Аннотация

TITLE: Prognosis of patients with early salvage radiotherapy and low persisting or increasing PSA levels after radical prostatectomy for prostate cancer. A retrospective comparative analysis.

INTRODUCTION

European prostate cancer guidelines include a "weak" recommendation to add hormonal therapy (ADT) to salvage radiotherapy (SRT) for better prognosis with persistent PSA values after radical prostatectomy (RP). In this study, prognosis with persistent PSA versus a PSA increase above undetectable after RP was compared.

METHODS

In this retrospective study of patients who underwent SRT to the prostate bed without ADT (pre-SRT-PSA ≤ 0.3 ng/ml), 243 patients had a PSA increase from undetectable (post-op PSA ≤ 0.05 ng/ml), and 110 patients had persisting PSA after RP (post-op PSA > 0.05 ng/ml). Primary endpoints: clinical progression-free survival (PFS), biochemical PFS (BPFS), metastasis-free survival (MFS), overall survival (OS).

Results

BPFS rates were 66.4% with low persistent PSA versus 71.6% with recurrent PSA (p = 0.253; median follow-up, 60 [25-92] months). The low-persistent and recurrent groups also did not differ for MFS, PFS, or OS (all p > 0.05). In univariate and multivariate analyses, T3-4 and Gleason grade 4-5 predicted BPFS; T-status, R-status (R1,2), and Gleason grade influenced PFS; Gleason grade predicted MFS; and T-status predicted OS. In multivariate analysis, PSA persistence did not predict any survival outcomes (all p > 0.05).

CONCLUSION

Prognosis with low persistent PSA values seems comparable to that with PSA levels increasing above undetectable. In the absence of other factors, ADT could be omitted in this favorable patient group. Prospective trials are needed.

Для цитирования: Thamm Reinhard, Scharl Sophia, Gartner Luca, Böhmer Dirk Heinz Gerhard, Siegmann Alessandra, Zips Daniel, Horsch Cornelia, Mayer Benjamin, Wiegel Thomas. Prognosis of patients with early salvage radiotherapy and low persisting or increasing PSA levels after radical prostatectomy for prostate cancer. A retrospective comparative analysis.. Clinical and translational radiation oncology. 2026. DOI: 10.1016/j.ctro.2026.101121.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.